View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Mansoor Raza Mirza, MD, and Ana Oaknin, MD, PhD, discuss the implications of recent advances in the use of molecular testing and classification to guide the use of immunotherapy for the treatment of patients with endometrial cancer.
Presenters:
Ana Oaknin, MD, PhD
Head of Gynecologic Tumors Unit
Medical Oncology Department
Vall d´Hebron University Hospital
Barcelona, Spain
Mansoor Raza Mirza, MD
Chief Oncologist
Department of Oncology,
Rigshopitalet – Copenhagen University Hospital
Copenhagen, Denmark
Experts provide their thoughts on key data in breast and gynecologic cancers from the 2022 ASCO Annual Meeting, from Clinical Care Options (CCO)
Joyce O'Shaughnessy, MD
Angeles Alvarez Secord, MD, MHSc
Physicians:
maximum of 1.5 AMA PRA Category 1 Credits™
Released: August 17, 2022
Expired:
August 16, 2023
Commentary on novel agents for platinum-resistant ovarian cancer, from Clinical Care Options (CCO)
Kathleen Moore, MD
Released: August 11, 2022
Interactive online tool with expert management recommendations for selecting therapy for women with ovarian cancer, from Clinical Care Options (CCO)
Robert L. Coleman, MD, FACOG, FACS
Linda R. Duska, MD, MPH
Thomas J. Herzog, MD
Kathleen Moore, MD
David O'Malley, MD
Released: August 5, 2022
Gain important nursing insights on the management of patients with gynecologic cancers in this program from Clinical Care Options (CCO)
Courtney Arn, CNP
Released: August 2, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.